As of 10:31 AM on the 7th, Optipharm is trading at 25,000 KRW, down 2.53% from the previous day. This represents a 17.37% increase compared to July 15.
Over the past five days, individual investors have net purchased 19,709 shares, while foreigners and institutions have net sold 11,927 shares and net purchased 10,163 shares, respectively.
On August 5, Optipharm was a market topic due to the news of being selected as a "COVID-19 vaccine testing institution," which led to a strong performance.
※ This article was generated in real-time by an automatic article generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
